Jason Haas

Affiliations

  • Chief Financial Officer at Syros Pharmaceuticals Inc. (SYRS), 2024-09-12
  • Director at Ligand Pharmaceuticals Inc (LGND), 2024-06-19
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SYRS $1.68 45,344 124,552 2024-09-12 Filing
SYRS $1.58 19,293 79,208 2024-09-11 Filing
SYRS $1.55 35,363 59,915 2024-09-10 Filing